RenovoRx

+$0.05 (+2.59%) Today
-$0.03 (-1.52%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RenovoRx and other ETFs, options, and stocks.

About RNXT

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors.

CEO
Shaun R. Bagai
Employees
—
Headquarters
Los Altos, California
Founded
2009

RNXT Key Statistics

Market cap
17.95M
Price-Earnings ratio
—
Dividend yield
—
Average volume
11.89K
High today
$1.95
Low today
$1.87
Open price
$1.87
Volume
3.96K
52 Week high
$16.74
52 Week low
$1.50

RNXT Earnings

-$0.33
-$0.26
-$0.19
-$0.12
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.21 per share
Actual
-$0.33 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure